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Plasma membrane translocation is challenging due to the barrier of cell membrane. Contrary to the 
synthetic cell-penetrating materials, tailed bacteriophages use cell-puncturing protein needles to puncture 
the cell membranes as an initial step of DNA injection process. Cell-puncturing protein needles are 
thought to remain functional in the native phages. In this paper, we found that a bacteriophage T4 derived 10 
protein needle of 16 nm length spontaneously translocates through the living cell membrane. β-helical 
protein needle (β-PN) internalizes into human red blood cells that lack endocytic machinery. By 
comparing the cellular uptake of β-PNs with modified surface charge, it is shown that the uptake 
efficiency is maximum when it has an negative charge corresponding to a zeta potential value of -16 mV. 
In HeLa cells, uptake of β-PN incorporates endocytosis independent mechanisms with partial 15 
macropinocytosis dependence. The endocytosis dependence of the uptake increases when the surface 
charges of β-PNs are modified to positive or negative. Thus, these results suggest that natural DNA 
injecting machinery can serve as an inspiration to design new class of cell-penetrating materials with 
tailored mechanism. 
Introduction 20 
Plasma membrane translocation of exogenous agents is a 
challenging task because of the semipermeable nature of the 
plasma membrane of the living cell.1 Most often natural and 
engineered cell-penetrating proteins and peptides are designed 
based on the theory of maximization of net positive charge in 25 
which exogenous “protein transduction domains” are appended 
by integration of the cationic functional groups as positive grafts 
to enhance the membrane permeability.2-4 However, in the 
nature’s design of highly efficient DNA injecting needles of 
viruses such as tailed bacteriophages, a structure based approach 30 
is chosen to achieve infection of host cells.5 Tailed 
bacteriophages use cell-puncturing needles such as gene product 
5 (gp5) of the bacteriophage T4 to puncture the cell membrane, 
facilitating the translocation of phage DNA into the cytoplasm 
(Fig. 1a).5-10 The torque force exerted onto gp5 is thought to be an 35 
important factor for penetration and is generated by a 
conformational change in the bacteriophage T4.11,12 The key 
structural feature of the gp5 is its needle structure that is formed 
by a triple-stranded β-helix (Fig. 1a).10 The β-helix consists of 
three monomers that form parallel β-sheets, resulting in a 40 
triangular prismatic needle structure.10 Highly repetitive amino 
acid sequences in the β-helix create a regular arrangement of 
amino acid residues on the surface. Since tailed bacteriophages 
share a common β-helix motif with similar diameters (1.5-2.5 





















Fig. 1. Structure of β-PN. (a) Crystal structure of gp5 of 
bacteriophage T4 presented as differently colored monomers.10 
N7 residues are depicted as blue space-filling models. (b) 
Structure of β-PN presented as differently colored monomers.13 
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an essential component of a cell-puncturing needle.10,14,15 A 
molecular dynamics simulation suggested that the greater 
stiffness of the β-helix in comparison to the cell membrane is 
optimized to maintain the needle structure during penetration.16,17 
Although negative charge of the surface of the β-helix is also 5 
anticipated to be important for the membrane-puncturing event, 
the detailed contribution of the surface charge on the membrane 
translocation is unknown.10,18 
 The presence of conserved β-helix motif in nature’s cell-
puncturing needles underscores the possibility of a structural 10 
basis of the membrane translocation phenomena. Although few 
recent studies have highlighted the implication of the protein 
secondary structure and conformation on cellular internalization 
of proteins, no clear connection between cellular uptake and their 
structural propensity is reported.19-22 A molecular dynamics 15 
simulation of membrane penetration of gp5 has indicated the 
importance of positively and negatively charged residues on the 
surface of the β-helix of gp5.12 The charged residues make strong 
hydrophilic interaction (e.g. H-bonds, charge) with lipids, waters, 
and neighboring residues, inducing the sliding of the lipids on the 20 
β-helix surface. Thus, it is expected that the natural pattern of the 
charged residues on the β-helix is crucial for the membrane 
translocation. 
 Here, we utilized a β-helical protein needle (β-PN) 
reconstructed from gp5 of the bacteriophage T4 (Fig. 1b)13 to 25 
investigate the membrane translocation of an isolated β-helix 
motif. β-PNs with different surface charges were synthesized, and 
the effect of charge on membrane translocation was examined. 
We demonstrate that β-PN spontaneously internalizes into human 
red blood cells (hRBCs) that lack endogenous endocytic 30 
machinery. The efficiency of uptake was found to depend on the 
surface charge of the β-PN. Whereas in HeLa cells, we observed 
that the predominant mechanism of cellular uptake of β-PN was 
guided by its surface charge. Our results suggest that the inherent 
structural features of the triple-stranded β-helix motif in β-PN 35 
enable it to spontaneously translocate through the membrane. 
This study demonstrates that natural biosupramolecular 
machinery may serve as source of inspiration for new approaches 
to the design of cell-penetrating materials. 
Results and discussion 40 
Modification of charged residues on β-PN 
The needle structure of β-PN is comprised of a homodimer with 
twisted triangular prismatic structure formed by intermolecular 
twist-lock interaction at the N-terminal yielding a β-helical 
needle of length 16 nm and diameter 2.4 nm (Fig. 1b).13 The 45 
fusion of β-helix motif with foldon at its termini stabilizes the 
trimer-dimer structure and prevents multimeric aggregation.13,23 
β-PN has alternatively arranged positive (Lys) and negative (Asp, 
Glu) residues along the rim of the triangular prism (Fig. 2a). 
Since surface charge plays an important role in most of the cell-50 
penetrating proteins and peptides, in order to illustrate the 
correlation between the membrane translocation of β-PN and 
surface charge, we have altered the surface charge of β-PN by 
chemical modification of surface exposed −COOH (Asp, Glu, 
and the C-terminus) and −NH2 groups (Lys and the N-terminus) 55 













Fig. 2. Modification of charged residues on β-PN. (a) Charged 
residues on β-PN. Asp and Glu (red) and Lys (blue) are 70 
represented as sticks. One of the six sides is enlarged in a detailed 
view. (b) A schematic drawing of the modification of charged 
residues of ATTO520-labeled β-PN (β-PN_A). Ethylenediamine 
was coupled to the –COOH groups of β-PN_A (to generate β-
PN_A_pos). Succinic anhydrides were coupled to the –NH2 75 
groups of β-PN_A (to generate β-PN_A_neg). 
 
Table 1. Size and surface charges of the needles 
 Hydrodynamic diameter (nm) Zeta potential (mV) 
β-PN_A 10 ± 1.2 –16 ± 1.7 
β-PN_A_pos 9.5 ± 1.7 +8.2 ± 0.4  
β-PN_A_neg 8.4 ± 1.4 –34 ± 2.7  
gp5_A 17 ± 4.8 –24 ± 1.2  
The hydrodynamic diameter was measured by DLS using 3 µM 
protein needle in 0.1 M sodium phosphate, pH 7.0. The surface 80 
charge was assessed by zeta potential measurements using 3 µM 
protein needle in 10 mM sodium phosphate, pH 7.4. 
 
 
introduced at G18 using site-directed mutagenesis were 85 
conjugated with the green fluorescent dye ATTO520-maleimide 
(Fig. 1b and 2b). MALDI-TOF analysis of β-PN_G18C 
conjugated with ATTO520 (β-PN_A) indicated a mass increase 
of 488 Da, which was assigned to an ATTO520-maleimide 
moiety (calcd. 492 Da), with the complete loss of the peak of the 90 
original β-PN_G18C monomer (14,847 Da) (Fig. S1a and S1b). 
This result indicates that all six G18C residues in β-PN were 
conjugated to ATTO520-maleimide molecules. The conversion 
of –COOH groups in β-PN_A to −NH2 groups was achieved by 
reaction of β-PN_A with ethylenediamine in the presence of N-95 
[3-(dimethylamino)propyl]-N'-ethylcarbodiimide (EDC) to 
generate positively charged β-PN_A (β-PN_A_pos) (Fig. 2b). 
MALDI-TOF analysis of the β-PN_A_pos monomer indicated a 
molecular weight of 15,975 Da (calcd. 15,962 Da), which 
accounts for the conjugation of 15 ethylenediamine molecules to 100 
each monomer (Fig. S1c). The fifteen surface exposed −COOH 
groups from Asp and Glu residues and the C-terminus (four –
COOH groups, from E78, D99, E104, and E109, of the β-PN_A 
monomer are buried, Fig. S2) were completely modified. The 
conversion of −NH2 groups in β-PN_A to –COOH groups was 105 
achieved by reaction of β-PN_A with succinic anhydride to 
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MALDI-TOF analysis of the β-PN_A_neg monomer indicated a 
molecular weight of 15,850 Da (calcd. 15,836 Da), which 
accounts for the conjugation of five –COOH groups to each 
monomer (Fig. S1d). The five surface-exposed −NH2 groups of 
the six −NH2 groups of Lys residues [−NH2 from K120 is buried 5 
(Fig. S2)] and the N-terminus of the β-PN_A monomer were 
completely modified. Gp5, consisting of the β-helix and three 
lysozyme domains, was utilized for comparison (Fig. 1a). N7C of 
gp5_N7C/S351L was modified with ATTO520-maleimide 
(gp5_A), and complete conjugation was verified by MALDI-TOF 10 
analysis (Fig. S1e and S1f). MALDI-TOF mass spectra of each 
needle include signals assignable to trimer-dimer of β-PN_As and 
trimer of gp5_A, indicating maintenance of the needle structure 
after the modifications (Fig. S1). The size of the needles was 
determined using dynamic light scattering (DLS) (Table 1 and 15 
Fig. S3). The modifications did not alter the size of the needles. 
These results indicate that there is no random aggregation or 
denaturation of the needle. The surface charge of the needles was 
determined by zeta potential measurements (Table 1). The zeta 
potential of β-PN_A (−16 mV) exhibited a negative surface 20 
charge in 10 mM sodium phosphate, pH 7.4. In contrast, the zeta 
potential of β-PN_A_pos (+8.2 mV) exhibited a positive surface 
charge, whereas the zeta potential of β-PN_A_neg (−34 mV) 
exhibited a negative surface charge. These results indicate that 
the surface charge of β-PN_A was successfully altered. 25 
Cellular uptake into hRBCs 
hRBCs were used to evaluate the non-endocytic membrane 
translocation because hRBCs lack endogenous endocytic 
machinery.24,25 hRBCs were incubated with the protein needles in 
an aqueous isotonic solution containing 0.9% (w/v) NaCl for 1 h 30 
at 37°C under 5% CO2. The cells were washed three times and 
observed using confocal microscopy (Fig. 3a-3d). Internalization 
of β-PN_A into hRBCs was indicated by the presence of a 
homogenous green fluorescence due to β-PN_A in the cytoplasm 
of hRBCs (Fig. 3a). However, endocytic markers such as 35 
transferrin and LacCer could not be internalized into hRBCs (Fig. 
S4).26 This result suggests that β-PN_A directly translocated 
through the plasma membrane of hRBCs. In contrast, β-
PN_A_pos predominantly accumulated on the membrane (Fig. 
3b). This accumulation may be induced by the electrostatic 40 
interaction between positively charged β-PN_A_pos (+8.2 mV) 
and the negatively charged hRBC membrane (–14 mV),27 thereby 
prohibiting translocation through the membrane. The uptake 
efficiency of β-PN_A_pos and β-PN_A_neg was 0.5 and 0.8 
times that of β-PN_A, respectively, as shown in Fig. 3e, which 45 
shows the uptake efficiency with respect to the zeta potential of 
each needle. The low translocation efficiency of β-PN_A_neg is 
expected to result from the greater negative charge (–34 mV) on 
the β-PN_A_neg surface in comparison to β-PN_A (–16 mV), 
which induces electrostatic repulsion with the membrane. These 50 
results indicate that among all of the protein needles, β-PN_A 
possesses the ideal surface charge required for membrane 
translocation. The uptake efficiency of gp5_A was 0.5 times that 
of β-PN_A (Fig. 3e). The presence of the three lysozyme 















































Fig. 3. Non-endocytic uptake into human red blood cells 
(hRBCs). Confocal fluorescence (top) and bright field (bottom) 
images of (a) β-PN_A, (b) β-PN_A_pos, (c) β-PN_A_neg, and 
(d) gp5_A in hRBCs (scale bars, 5 µm). Each needle was 105 
incubated with hRBCs for 1 h in 0.9% NaCl at 37°C under 5% 
CO2. (e) The uptake efficiency into hRBCs with respect to the 
zeta potentials of each needle. The relative uptake percentage was 
determined from the integrated fluorescence intensity of the 
intracellular section normalized to the area of the section from the 110 
respective images (Fig. S5). The data represent mean ± SEM (n = 
11). The concentration of ATTO520 was adjusted to 10 µM for 
comparison of the fluorescence intensity. The concentration of β-
PN_A, β-PN_A_pos, and β-PN_A_neg was 1.7 µM, whereas that 










































































































































Fig. 4. Uptake into HeLa cells. Confocal fluorescence images of 
(a) β-PN_A, (b) β-PN_A_pos, (c) β-PN_A_neg, and (d) gp5_A 
in HeLa cells (scale bars, 10 µm). Each needle was incubated 
with HeLa cells for 1 h in medium at 37°C under 5% CO2. Cell 55 
nuclei were labeled with blue fluorescent Hoechst 33342. (e) 
Cellular uptake efficiency into HeLa cells with respect to the zeta 
potential of each needle. The relative uptake percentage was 
determined using flow cytometry after incubation for 1 h. The 
data represent mean ± SEM (n = 3). (f) Flow cytometry analysis 60 
indicating the percentage of cells that contained internalized 
needles following 1 h incubation with HeLa cells that were 
pretreated with various pharmacological inhibitors of endocytosis, 
normalized to untreated cells. The relative uptake was normalized 
using cells which were treated with each needle in the absence of 65 
any inhibitor (positive control, 100% uptake). The data represent 
mean ± SEM (n = 3). *P < 0.05 compared to positive control. The 
concentration of ATTO520 was adjusted to 5 µM for comparison 
of the fluorescence intensity. The concentration of β-PN_A, β-
PN_A_pos, and β-PN_A_neg was 0.83 µM, whereas that of 70 
gp5_A was 1.7 µM. 
 
Cellular uptake into HeLa cells 
The uptake mechanism of β-PN_A into typical mammalian cells 
was evaluated using HeLa cells. Upon incubation of β-PN_A 75 
with HeLa cells for 1 h, green fluorescence was observed in the 
cytoplasm, indicating the internalization of β-PN_A (Fig. 4a). It 
was confirmed that the needle internalized into HeLa cells 
without decomposition, aggregation, and cytotoxicity as 
described in the Supporting Information. In contrast to hRBCs, β-80 
PN_A_pos did not accumulate on the membranes of HeLa cells 
but was rather internalized (Fig. 4b). β-PN_A_neg and gp5_A 
were internalized as observed in hRBCs (Fig. 4c and 4d). The 
uptake efficiency of each needle was compared using flow 
cytometry analysis after 1 h incubation (Fig. 4e). In contrast to 85 
the observations in hRBCs (Fig. 3e), the uptake efficiency of β-
PN_A_pos and β-PN_A_neg were 2.1 and 1.5 times that of β-
PN_A, respectively. These results suggested that the increase in 
the uptake efficiency of β-PN_A_pos and β-PN_A_neg in HeLa 
cells was due to endocytosis. To verify this hypothesis, the 90 
internalization efficiency in HeLa cells was evaluated in the 
presence of different pharmacological inhibitors of endocytosis 
(Fig. 4f).26,28 The protein needles were incubated with HeLa cells 
for 1 h after pretreatment with each inhibitor. Significant 
inhibition of the cellular uptake of β-PN_A was not observed for 95 
any inhibitor (< 22%) except for rottlerin (40%), which has been 
reported to inhibit macropinocytosis.29 Because amiloride, which 
is also an inhibitor of macropinocytosis, exhibited decreased 
inhibition (7.2%), the uptake of β-PN_A was concluded to be 
partially dependent on macropinocytosis. Cellular uptake of β-100 
PN_A into HeLa cells was evaluated in the presence of rottlerin 
using confocal microscopy (Fig. S6). Homogeneous green 
fluorescence with disappearance of dot-like structures in 
cytoplasm clearly indicated non-endocytic uptake of β-PN_A. 
For β-PN_A_pos, significant inhibition of the uptake by several 105 
inhibitors in comparison to β-PN_A revealed the dependence on 
multiple endocytic pathways (Fig. 4f). Uptake of β-PN_A_neg 
and β-PN_A was primarily inhibited by rottlerin, but the 
inhibitory efficiency (83%) was greater for β-PN_A_neg than for 
β-PN_A (Fig. 4f). For gp5_A, cell uptake was inhibited by 110 
several inhibitors, including cytochalasin D, bafilomycin A1, and 
rottlerin, indicating a dependence on multiple endocytic pathways 
(Fig. 4f). These results indicated that β-PN_A exhibits the least 
dependence on endocytosis among all of the needles, whereas β-
PN_A_pos and β-PN_A_neg were highly dependent on this 115 
mechanism.  
















Fig. 5. KCl-dependence on relative uptake percentage of β-PN_A 
into HeLa cells. β-PN_A (0.83 µM) was incubated with HeLa 
cells in the medium with various concentrations of KCl for 1 h at 
37°C under 5% CO2. The relative uptake percentage was 
determined using flow cytometry. The data represent mean ± 20 
SEM (n = 3). *P < 0.05 compared to cells that were treated with 
β-PN_A in the medium containing 5 mM KCl. 
 
Membrane potential dependence of cellular uptake of β-
PN_A 25 
While cellular uptake of β-PN_A in hRBCs and HeLa cells could 
prove the non-endocytic mode of cell entry of β-PN_A, it is 
important to explain the driving force required for this process. 
Membrane potential has been reported to provide the energy for 
the DNA internalization during the infection process of 30 
bacteriophages T4, T7, and P22.8,30-33 Therefore, the uptake 
efficiency of β-PN_A in HeLa cells was evaluated in the presence 
of different concentrations of extracellular KCl that reduces the 
membrane potential of viable cells.34 The uptake efficiency was 
decreased with increasing extracellular KCl concentration (Fig. 5). 35 
One of the reasons of the decreased uptake efficiency is expected 
to be due to inhibition of cellular binding of negatively charged 
β-PN_A by decrease of membrane potential as reported in 
anionic nanoparticle.35 
Discussion 40 
Comparison of the cellular uptake of the evaluated protein 
needles into hRBCs and HeLa cells revealed the effect of the 
surface charge of the protein needles on the mechanism and the 
efficiency of membrane translocation. In hRBCs, β-PN_A with a 
threshold value of -16 mV exhibited a non-endocytic mode of 45 
membrane translocation with the highest efficiency among all of 
the protein needles (Fig. 3e). In contrast, β-PN_A_pos that has a 
zeta potential value of +8.2 mV predominantly adsorbed on the 
membrane surface owing to the strong electrostatic interaction 
with the negatively charged hRBC membrane, as shown in Fig. 50 
3b.27 Increase in the negative charge as in the case of β-
PN_A_neg with a zeta potential value of -34 mV reduces the 
efficiency of membrane translocation. It is expected to be due to 
stronger repulsion with the hRBC surface. In the HeLa cells, the 
uptake efficiency was the highest for β-PN_A_pos (Fig. 4e). The 55 
endocytosis inhibition studies indicated that the uptake of β-
PN_A_pos was induced by several endocytosis- and 
macropinocytosis-dependent pathways due to electrostatic 
interaction with HeLa cell membranes, like that of positively 
charged cell-penetrating peptides and proteins (Fig. 4f).3,36-39 60 
Whereas β-PN_A translocates through the membrane 
predominantly with the non-endocytic mode due to electrostatic 
repulsion to the membranes though 40% contribution of 
macropinocytosis is also present, in agreement with study of 
differently charged polymers.40 The uptake efficiency of β-PN in 65 
HeLa cells was about half of that of positively charged cell-
penetrating peptide, octaarginine (R8) (Supporting Information, 
Fig. S11).41 The mechanism of membrane translocation of β-
PN_A_neg is predominantly the macropinocytosis pathway 
induced by the stronger negative charge on β-PN_A_neg 70 
compared to β-PN_A, as observed for negatively charged 
polymers (Fig. 4f).40 These results suggest that the amount of 
negative charge on β-PN_A is appropriate to facilitate the non-
endocytic mode of membrane translocation in both hRBCs and 
HeLa cells. 75 
 The spontaneous membrane translocation of β-PN_A provides 
insight into the mechanism of infection of tailed bacteriophages. 
The infection of some tailed bacteriophages has been reported to 
require a membrane potential.8,30-33 However, it is not yet clear 
which step of infection is driven by the membrane potential.8 The 80 
membrane translocation of β-PN_A into HeLa cells is dependent 
on the extracellular KCl concentration. Since higher extracellular 
KCl decreases the membrane potential,34 our result suggests that 
the membrane potential may be one of the driving forces that 
govern the β-PN_A membrane translocation process. Therefore, 85 
membrane puncturing by protein needles during bacteriophage 
infection may represent the step that requires a membrane 
potential. 
Conclusions 
We found membrane translocation of the protein needles derived 90 
from bacteriophage T4 and provided a structural insight into the 
mechanism. We envision that β-helix motif based protein needles 
can be utilized for efficient in vitro and in vivo delivery of large 
molecular cargos, such as proteins and nucleic acids, directly into 
the cytoplasm. Therefore, this study presents a new approach of 95 
designing cell-penetrating materials from the natural 
biosupramolecular machineries. Since the terminal structure of β-
PN is expected to be important for attachment to the membrane, 
modification of foldon domain of β-PN is in progress to elucidate 
the detailed mechanism of the membrane translocation of β-PN. 100 
Experimental section 
Labeling with ATTO520 
β-PN_A: A DMSO solution of ATTO520-maleimide (ATTO-
TEC, 60 µM) was slowly added to an aqueous solution of β-
PN_G18C (5 µM in 20 mM potassium phosphate, pH 7.0), and 105 
the mixture (final concentration of 5% DMSO) was gently stirred 
at 25°C for 15 h in the dark. β-PN_A was purified using 
Sephadex G-25 that was equilibrated with 0.1 M sodium 
phosphate, pH 7.0. MS (MALDI-TOF): [β-PN_G18C monomer + 
ATTO520-maleimide]+, calcd.: 15,335; found: 15,331. Gp5_A: A 110 
DMSO solution of ATTO520-maleimide (105 µM) was slowly 
added to an aqueous solution of gp5_N7C/S351L (7 µM in 20 
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mM Tris-HCl, pH 8.0, 0.2 M NaCl, 0.5 mM TCEP-HCl), and the 
mixture (final concentration of 5% DMSO) was gently stirred at 
18°C for 3 h in the dark. Gp5_A was purified using Sephadex G-
25 that was equilibrated with 0.1 M sodium phosphate, pH 7.0. 
MS (MALDI-TOF): [gp5_N7C/S351L monomer + ATTO520-5 
maleimide]+, calcd.: 64,747; found: 65,275. 
Modification of the surface charge of β-PN_A  
β-PN_A_pos: β-PN_A (2.0 µM in 0.1 M sodium phosphate, pH 
7.0) was slowly added to an aqueous solution of ethylenediamine 
dihydrochloride (1.6 M in 0.1 M sodium phosphate, pH 7.0).  10 
EDC was added to the mixture (final concentration: 10 mg/mL). 
The mixture was gently stirred at 25°C for 5 h in the dark. β-
PN_A_pos was purified using Sephadex G-25 that was 
equilibrated with 0.1 M sodium phosphate, pH 7.0. MS (MALDI-
TOF): [β-PN_G18C monomer + ATTO520-maleimide + 15 15 
−NH2 modifications]+, calcd.: 15,962; found: 15,975. β-
PN_A_neg: A DMSO solution of succinic anhydride (18 mM) 
was slowly added to an aqueous solution of β-PN_A (5.0 µM in 
0.1 M sodium carbonate, pH 9.0), and the mixture (final 
concentration of 10% DMSO) was gently stirred at 25°C for 16 h 20 
in the dark. β-PN_A_neg was purified using Sephadex G-25 that 
was equilibrated with 0.1 M sodium phosphate, pH 7.0. MS 
(MALDI-TOF): [β-PN_G18C monomer + ATTO520-maleimide 
+ 5 −COOH modifications]+, calcd.: 15,836; found: 15,850. 
Confocal imaging of hRBCs  25 
hRBCs (3 × 105 cells) in a 0.9% NaCl solution were plated onto 
single-well glass-bottom dishes, which were coated with 1.2 
mg/mL poly-L-lysine for 3 h and subsequently washed with 0.9% 
NaCl. The cells were allowed to adhere by incubation for 1 h at 
37°C under 5% CO2. After washing with 0.9% NaCl, β-PN_A, β-30 
PN_A_pos, β-PN_A_neg (each at a concentration of 1.7 µM), or 
gp5_A (3.3 µM) were added and incubated for 1 h. The 
concentration of ATTO520 was adjusted to 10 µM for 
comparison of the fluorescence intensity. The cells were washed 
with a 0.9% NaCl solution and imaged (excitation using a 488-35 
nm laser and observed through a 525/50 emission filter). Uptake 
efficiency into the cells was quantified from the integrated 
fluorescence intensity of the intracellular section that was 
normalized to the area of the section (Fig. S5). Eleven cells were 
analyzed for each sample to calculate the intensity to obtain the 40 
average value and standard deviation. Dextran Oregon Green® 
488; 70,000 MW (Invitrogen), which cannot be internalized into 
red blood cells, was used as a negative control.42 
Experiments with HeLa cells  
Confocal imaging 45 
HeLa cells (2.0 × 104 cells) were plated onto single-well glass-
bottom dishes and cultured in cell culture medium at 37°C under 
5% CO2 for 12 h. β-PN_A, β-PN_A_pos, β-PN_A_neg (each at a 
concentration of 0.83 µM), or gp5_A (1.7 µM) were added and 
incubated for 1 h. The concentration of ATTO520 was adjusted 50 
to 5 µM for comparison of the fluorescence intensity. The 
medium was removed, and the cells were washed with 1× HBSS. 
The nucleus was labeled with Hoechst 33342 (5 µg/mL) 
(Invitrogen) by incubating the cells with the dye solution in 
HBSS for 15 min at 37°C under 5% CO2. The dye solution was 55 
removed, and the cells were washed with 1 × HBSS. Imaging was 
performed in fresh cell culture medium. ATTO520-labeled 
samples, Hoechst 33342 were excited with 488 nm and 405 nm 
lasers and were observed through 525/50 and 450/50 emission 
filters, respectively. 60 
Cellular uptake analysis 
HeLa cells (1.3 × 105 cells) were plated in 1.5 cm dishes and 
cultured in cell culture medium at 37°C under 5% CO2 for 12 h. 
β-PN_A, β-PN_A_pos, β-PN_A_neg (each at a concentration of 
0.83 µM), or gp5_A (1.7 µM) were added to the cells and 65 
incubated for 1 h. The culture medium was removed, and the 
cells were washed with 1 × PBS. The cells were collected by 
trypsinization and centrifugation followed by suspension in 1 × 
PBS with 5% FBS. Cellular uptake was analyzed using flow 
cytometry. Each sample was analyzed three times. 70 
Inhibition of endocytosis 
For all inhibition studies, HeLa cells (2 × 105 cells) were plated in 
1.5 cm dishes and cultured in cell culture medium at 37°C under 
5% CO2 for 12 h. The cells were preincubated with endocytic 
inhibitors (400 µM genistein, 5 µg/mL nocodazole, 50 µM 75 
cytochalasin D, or 40 nM bafilomycin A1 for 1 h and 0.45 M 
sucrose, 3 mM MβCD, 80 µM dynasore, 10 mM NaN3 with 50 
mM 2-deoxy-D-glucose for ATP depletion, 4 mM amiloride, or 
10 µM rottlerin for 30 min) in cell culture medium without FBS. 
The cells were washed and incubated with β-PN_A, β-PN_A_pos, 80 
β-PN_A_neg (each at a concentration of 0.83 µM), or gp5_A (1.7 
µM) for 1 h. The cells were washed with 1 × PBS, and cellular 
uptake was analyzed using flow cytometry as previously 
described. Each sample was analyzed three times. Inhibition 
conditions were optimized by analyzing the uptake of 85 
endocxytosis markers after incubation of 16.7 µg/mL human 
Transferrin (hTf)-AlexaFluor488 (Invitrogen) or 0.81 µM BSA-
complexed BODIPY FL C5-Lactosylceramind (LacCer) 
(Invitrogen) for 15 min and 0.5 mg/mL Oregon Green labeled 70 
kDa dextran (Invitrogen) for 3 h in HeLa cells that were 90 
pretreated with the endocytosis inhibitors, as previously 
described.26 
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